196 related articles for article (PubMed ID: 17656390)
1. Innovation - drugs and diagnostics.
Finch R
J Antimicrob Chemother; 2007 Aug; 60 Suppl 1():i79-82. PubMed ID: 17656390
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic resistance--action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12-13 December 2005.
Finch R; Hunter PA
J Antimicrob Chemother; 2006 Sep; 58 Suppl 1():i3-i22. PubMed ID: 17003063
[TBL] [Abstract][Full Text] [Related]
3. 18 November and beyond: observations on the EU Antibiotic Awareness Day.
Finch R; Sharland M
J Antimicrob Chemother; 2009 Apr; 63(4):633-5. PubMed ID: 19223300
[TBL] [Abstract][Full Text] [Related]
4. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe.
Ferech M; Coenen S; Malhotra-Kumar S; Dvorakova K; Hendrickx E; Suetens C; Goossens H;
J Antimicrob Chemother; 2006 Aug; 58(2):401-7. PubMed ID: 16735414
[TBL] [Abstract][Full Text] [Related]
5. Reducing antimicrobial resistance through appropriate antibiotic usage in Singapore.
Hsu LY; Kwa AL; Lye DC; Chlebicki MP; Tan TY; Ling ML; Wong SY; Goh LG
Singapore Med J; 2008 Oct; 49(10):749-55. PubMed ID: 18946605
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance: paradox, actions and economics.
Wise R
J Antimicrob Chemother; 2006 Jun; 57(6):1024-5. PubMed ID: 16624875
[TBL] [Abstract][Full Text] [Related]
7. [International strategies and campaigns to promote the prudent use of antibiotics by health professionals and patients].
Campos J; Pérez-Vázquez M; Oteo J
Enferm Infecc Microbiol Clin; 2010 Nov; 28 Suppl 4():50-4. PubMed ID: 21458702
[TBL] [Abstract][Full Text] [Related]
8. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic stewardship implementation in the EU: the way forward.
Allerberger F; Gareis R; Jindrák V; Struelens MJ
Expert Rev Anti Infect Ther; 2009 Dec; 7(10):1175-83. PubMed ID: 19968511
[TBL] [Abstract][Full Text] [Related]
10. An outcome-based approach for teaching prudent antimicrobial prescribing to undergraduate medical students: report of a Working Party of the British Society for Antimicrobial Chemotherapy.
Davenport LA; Davey PG; Ker JS;
J Antimicrob Chemother; 2005 Jul; 56(1):196-203. PubMed ID: 15914493
[TBL] [Abstract][Full Text] [Related]
11. [European Antibiotic Awareness Day--why needed?].
Hryniewicz W; Mazińska B
Pol Merkur Lekarski; 2009 Oct; 27(160):261-4. PubMed ID: 19928651
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial prescribing policy and practice in Scotland: recommendations for good antimicrobial practice in acute hospitals.
Nathwani D; ;
J Antimicrob Chemother; 2006 Jun; 57(6):1189-96. PubMed ID: 16624876
[TBL] [Abstract][Full Text] [Related]
13. Mapping antibiotic use and resistance in the Netherlands: SWAB and NethMap.
Verbrugh HA
Neth J Med; 2003 Nov; 61(11):341-2. PubMed ID: 14768715
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic resistance. An impending crisis.
Mah MW; Memish ZA
Saudi Med J; 2000 Dec; 21(12):1125-9. PubMed ID: 11360084
[TBL] [Abstract][Full Text] [Related]
15. Report of the Consensus Conference on Antibiotic Resistance; Prevention and Control (ARPAC).
MacKenzie FM; Struelens MJ; Towner KJ; Gould IM; ;
Clin Microbiol Infect; 2005 Nov; 11(11):938-54. PubMed ID: 16216115
[TBL] [Abstract][Full Text] [Related]
16. The European Antibiotic Awareness Day.
McNulty CA; Johnson AP
J Antimicrob Chemother; 2008 Nov; 62(5):853-4. PubMed ID: 18819969
[TBL] [Abstract][Full Text] [Related]
17. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic use in Germany and European comparison.
De With K; Schröder H; Meyer E; Nink K; Hoffmann S; Steib-Bauert M; Kämmerer R; Ruess S; Daschner FD; Kern WV
Dtsch Med Wochenschr; 2004 Sep; 129(38):1987-92. PubMed ID: 15375742
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges.
Thomson CJ; Power E; Ruebsamen-Waigmann H; Labischinski H
Curr Opin Microbiol; 2004 Oct; 7(5):445-50. PubMed ID: 15451498
[TBL] [Abstract][Full Text] [Related]
20. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis.
Kelly R; Zoubiane G; Walsh D; Ward R; Goossens H
Lancet Infect Dis; 2016 Apr; 16(4):431-40. PubMed ID: 26708524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
